Skip to content
University of Colorado Anschutz Medical Campus CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 

Tools & Resources

  • Events Calendar
  • Newsroom
  • Strauss Health Sciences Library
  • Department A-Z Directory
  • Campus Directory
  • Leadership
  • Faculty & Staff Resources
  • Supporter & Alumni Resources
  • Student Resources
  • Campus Map
  • University Policies
  • Give Now

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU System
  • CU Online

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

IT MATTTRs™

School of Medicine

  • Home
  • About Us
    • Meet The Team
  • Train Your Practice
  • Community Awareness Materials
    • Have You Met MAT?
    • MAT In The SLV
  • MAT Resources
  • Contact Us
University Quick Links

MAT Resources


IT MATTTRsTM partners with several organizations and programs to provide a range of MAT resources and support for practices and clinicians.


MAT Resources Toolkit

IT MATTTRsTM collaborated with several partners to provide a collection of resources, guides, and tools to assist practices in treating patients with opioid use disorder (OUD).  The MATerials Resource Toolkit provides sample handouts, protocols, and procedures for practices to effectively treat or refer patients with OUD.

If you are a practice that has completed the IT MATTTRsTM Practice Team Training and would like to request an additional hard copy of the MATerials toolkit, please complete the MATerials request form. 

The MATerials include 10 chapters of resources:

AUDIT (Alcohol Use Disorders Identification Test)
The AUDIT is a simple way to screen and identify people at risk of alcohol problems. 

Drug Abuse Screening Test (DAST-10)
The DAST-10 is a 10-item brief screening tool that assesses drug use, not including alcohol use, over the past 12 months. 

Criteria for Diagnosis of Opioid Use Disorder (DSM-5)
Identifying problematic pattern of opioid use leading to clinically significant impairment or distress over the past 12 months.

Drug Screening Treatment Referral Form
This form can be used to outline patient referrals, and substance involvement. 

ASAM Urine Testing Resources
American Association of Addiction Medicine (ASAM) links for webinars and electronic pocket guides for additional information on drug testing. 

Buprenorphine Initiation Checklist for Clinics
This checklist, to be completed by a clinical staff member, is a sample of what the clinical process can look like for intake of an OUD patient that is ready to begin MAT.

Patient Consent Form
Sample MAT consent form, including purpose, practice policies/procedures, and reasons for dismissal from suboxone treatment program.

Buprenorphine Treatment Agreement (Sample 1)
Sample treatment agreement form that can be used for patients who are beginning long-term MAT. This agreement outlines risks associated with suboxone, voluntary consent for treatment, patient and prescriber responsibilities, etc.

Buprenorphine Treatment Agreement (Sample 2)
Sample treatment agreement form that can be used for patients who are beginning long-term MAT. This agreement outlines risks associated with suboxone, voluntary consent for treatment, patient and prescriber responsibilities, etc.  

MAT Program Overview

Sample handout for OUD patients that includes an overview of MAT, benefits of buprenorphine, and what to expect during MAT visits.

Buprenorphine Information Sheet 

Informational handout for patients about buprenorphine.

Clinical Opiate Withdrawal Scale (COWS) 

The COWS is an 11-item scale designed to be administered by a clinician to identify and monitor signs and symptoms of opioid withdrawal. 

Subjective Opiate Withdrawal Scale (SOWS) 

The SOWS is a 16-item scale designed to be completed by a patient to rate intensity of withdrawal on a 5-point scale.

Office Induction Protocol for Practices 

A sample of what the first 3 days of an induction might look like for the patient and the practice.  Includes when to administer the COWS, withdrawal observation guidelines, and maximum day doses.  

Unobserved Home Induction Clinic Protocol

A guide for the clinic to follow when doing unobserved (home) inductions for patients.

Observed Phone or Video (Telehealth) Induction Clinic Protocol

A guide for the clinic to follow when doing an observed telehealth induction (by phone or video) for patients.

Unobserved Home Induction Patient Guide

A guide for the patient to use for an unobserved (home) buprenorphine induction.

Induction Day Care Plan

Sample form to be completed by the patient that outlines supports, goals, and self-care during induction period.

Maintenance Care Plan

Sample form to be completed by the patient that outlines supports, triggers, emotional/physical relapse, self-care, goals, and coping skills during the maintenance period.

Side Effect Management Protocol

A resource for managing side effects of opioids.

Relapse Flowchart

Sample practice flowchart for delivering MAT care to patients that relapse. 

History of Present Illness (HPI) Assessment and Plan Template

Includes templates for induction and follow-up appointments for MAT in OUD, and suboxone script writing. Can be saved electronically to cut/paste into EHR.

Billing & Coding for MAT

MAT billing and coding background, information, considerations, and procedures for patient visits.

Billing and Coding considerations for MAT & OUD

PowerPoint presentation created by an IT MATTTRs expert consultant about billing and coding considerations for OUD and MAT.

MAT and C-Sections
Managing pain for patients that will deliver by c-sections and sample MAT for c-sections.

OpiSafe Sales Sheet

OpiSafe is a comprehensive online support system for opioid prescribers that meets regulatory requirements for managing opioid prescribing and MAT.

OpiSafe Teamwork Flyer
OpiSafe Teamwork is an engagement tool for patients during office visits without compromising patient privacy.

SBIRT in Colorado (Screening, Brief Intervention, Referral to Treatment)
Screening, Brief Intervention, and Referral to Treatment is an evidence-based early intervention to prevent alcohol and drug use problems in adults and adolescents.  No-cost training and technical assistance can be accessed using this handout.

SBIRT Reimbursement
List of commonly used CPT codes for screening and brief intervention services that can be used for reimbursement.

Cycle of Addiction

Taken from the IT MATTTRs primary care practice team curriculum, this handout provides a visual of the Cycle of Addiction.

The words we use matter (NAABT) 
Information about reducing stigma of opioid use disorder through language. 

Opioid names: Brand, Generis, Street, and Combination
List of various names associated with opioids, combination prescriptions, and street names. 

Alternatives to Buprenorphine

Alternatives to buprenorphine with descriptions of benefits, limitations, and potential candidates. 

Urine Drug Screening Article (ASAM)

Information about drug screening from the American Society of Addiction Medicine (ASAM). 

Rethinking JCAHO Pain Standards (JAMA)

Information about lessons learned to help inform efforts to address the prescription opioid crisis. 

MAT Implementation Checklist

Practice checklist to evaluate and consider level of MAT implementation within clinic.

Buprenorphine Patient Limits

History and overview of patient limits.

Blank Local Resources Logs (BHPs, MAT prescribers, Community resources)

Use these sections to track community resources for referrals, support, or additional sources of information in your region.

 

Law Enforcement Treatment Partnership
Information about learning the language, accepting the differences, and embracing the goals between law enforcement and treatment programs.

 

Administering Naloxone

Guidance for first responders administering Naloxone.

Take Meds Seriously (Colorado-only)

Information to access resources about safe use, safe storage, safe disposal (Take Back Program location finder), and resources.

Colorado Opioid Legislation Summary for 2019

Description of Colorado opioid-related legislation passed in 2019.

Recent Colorado Opioid Legislation Summary

CAGE Questionnaire Adapted to Include Drugs (CAGE-AID) 

Version of the CAGE alcohol screening questionnaire, adapted to include drug use. Target population for this tool includes both adults and adolescents. 

NIDA Quick Screen 

Assist clinicians serving adult patients in screening for drug use.

NIDA Quick-Screen: Lifetime & Substance Involvement (SI) Score

Assesses lifetime & Substance Involvement (SI) Score.

NIDA Screening for Drug Use in General Medical Settings

Quick Reference Guide for identifying drug users, providing education, and referral to resources for quitting.

Two-Item Conjoint Screen (TICS) 

Two question screening tool on alcohol/drug use in the past year, and the need to cut down on use.

Current Opioid Misuse Measure (COMM)

Brief patient self-assessment to monitor chronic pain patients on opioid therapy.

CRAFFT Screening Interview
6-question behavioral health screening tool for children under the age of 21.

 

Columbia-Suicide Severity Rating Scale (C-SSRS) Risk Assessment

Questionnaire used for suicide assessment.

Columbia-Suicide Severity Rating Scale

Questionnaire used for suicide assessment.

Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES v8)
Assesses readiness for change in alcohol misuse.

 

SOCRATES 8D: Personal Drug Use Questionnaire

Assesses readiness for change in alcohol abusers.

Brief Situational Confidence Questionnaire (BSCQ)

Assesses self-confidence to resist the urge to drink heavily or use drugs in situations.

Alcohol (and Illegal Drugs) Decisional Balance Scale

20-item self-report measure to assess an individual’s pros and cons of health behaviors. 

42 CFR Part 2 – Comparison Chart

Comparison between 42CFR Part 2 (1987 Rule) and 42 CFR Part 2 (Updated Final Rule).


Practice Team Training in Opioid Use Disorder and Medication Assisted Treatment

Designed for primary care and behavioral health care teams, the IT MATTTRsTM Practice Team Training gives all members of the practice team a common set of knowledge and language around OUD and MAT, and supports team-based care for effective education and care coordination.  For more information, visit the Train Your Practice page. 


Clinician Waiver Training

Several national organizations offer online training for clinicians to receive the required waiver to prescribe buprenorphine for opioid use disorder. These include our partners at:

  • The American Society of Addiction Medicine (ASAM) Treatment of Opioid Use Disorder Course provides required education for clinicians to identify, assess, diagnose, and manage patients with OUD.  ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 
  • Providers Clinical Support System (PCSS-MAT) provides trainings on a broad range of substance use disorder treatments, focusing on OUD, and offers waiver-qualifying MAT training to clinicians. 
  • Practice Innovation Practice Innovation ProgramProgram at the University of Colorado provides free trainings to providers to obtain their DEA waiver required to prescribe MAT for OUD through a hybrid training model.  This model offers a 4-hour online, group session with a practicing MAT clinician expert.  Trainees complete the remaining 4 hours on their own.  Visit the Practice Innovation Program for more information.

MAT Webinars

Our partners at the Practice Innovation Program at the University of Colorado also offers online forums and webinars that cover a variety of MAT topics.  Descriptions and schedules are available on their website. 


Substance Use Warmline

Have a question?  Need to talk with someone experienced in providing MAT? 

The National Clinician Consultation Center offers free and confidential clinician-to-clinician telephone consultation focusing on substance use evaluation and management for primary care clinicians through the Substance Use Warmline at (855) 300-3595.

Consultation is available Monday through Friday, between 9 a.m. and 8 p.m ET, from addiction medicine-certified physicians, clinical pharmacists, and nurses with special expertise in pharmacotherapy options for opioid use.

Voicemail is available 24-hours a day and this service is available to clinicians anywhere in the country. 


Home vs. Office for Medication Enhanced Recovery (HOMER)

HOMER is a new national study comparing three methods of induction for MAT for OUD. 

This study will help determine if certain patient and practice characteristics make patients better candidates for one method over the others.  Results will help fill a gap in the evidence around effectively treating OUD with MAT in primary care settings.  The three methods are: 1) home induction (asynchronous, unobserved), 2) office induction (synchronous, observed), and 3) telehealth induction (synchronous phone or video contact, observed). 

Fill out the HOMER Interest Survey if you’d like to be a part of this study.


Airplane-Banner-Special

IT MATTTRs cropped logo BLACK_Oct 2020

IT MATTTRs™

CU Anschutz

Academic Office One

12631 East 17th Avenue

Box F496

Aurora, CO 80045


itmatttrs@cuanschutz.edu

Department of Family Medicine
  • Family Medicine website
SNOCAP
  • Website
  • Facebook
  • Twitter
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window